Earnings Feed
Start Free
MYRIAD GENETICS INC·4

May 29, 3:58 PM ET

HOBDEN ADRIAN N 4

4 · MYRIAD GENETICS INC · Filed May 29, 2009

Insider Transaction Report

Form 4
Period: 2009-05-27
MYRIAD GENETICS INCMYGN
HOBDEN ADRIAN N
Pres. Myriad Pharmaceuticals
Transactions
  • Exercise/Conversion

    Common Stock

    2009-05-27$2.39/sh+40,000$95,620→ 235,726 total
  • Sale

    Common Stock

    2009-05-27$34.01/sh−40,000$1,360,568→ 195,726 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2009-05-27−40,000→ 0 total
    Exercise: $2.39Exp: 2009-06-17→ Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]20% vests annually beginning on the 1st anniversary of the date of the Option Grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT